Cericlamine

Cericlamine
Clinical data
Routes of
administration		 Oral[1]
ATC code None
Pharmacokinetic data
Biological half-life 8 hours[1]
Identifiers
CAS Number 112922-55-1
PubChem (CID) 131074
ChemSpider 115890
UNII VES82D23IB YesY
Chemical and physical data
Formula C12H17Cl2NO
Molar mass 262.17548 g/mol
3D model (Jmol) Interactive image

Cericlamine (INN) (developmental code name JO-1017) is a potent and moderately selective serotonin reuptake inhibitor (SSRI) of the amphetamine family (specifically, a derivative of phentermine, and closely related to chlorphentermine, a highly selective serotonin releasing agent) that was investigated as an antidepressant for the treatment of depression, anxiety disorders, and anorexia nervosa by Jouveinal but did not complete development and was never marketed.[1][2][3][4] It reached phase III clinical trials in 1996 before development was discontinued in 1999.[5]

Synthesis

Cericlamine synthesis:[6]

Arylation of methacrylic acid with a diazonium salt of 3,4-dichloroaniline (or 3,4-dichloro-benzenediazonium salt), is carried out according to the Meerwein reaction catalysed by a metallic halide. For the next step, the halide is displaced by dimethylamine, then esterification is performed, followed by reduction with a metal hydride.

See also

References

  1. 1 2 3 Darcourt, G.; Tessera, M.; Lesaunier, R.; Engrand, P.; Scherrer, B.; Dreyfus, J. F.; Bogaievsky, Y. (1992). "A MULTICENTRE DOUBLE-BLIND, PLACEBO-CONTROLLED DOSE-FINDING STUDY WITH CERICLAMINE IN MAJOR DEPRESSION.". Clinical Neuropharmacology. 15: 176B. doi:10.1097/00002826-199202001-00339. ISSN 0362-5664.
  2. ↑ Crow, Scott; Brown, Eric (2003). "Investigational drugs for eating disorders". Expert Opinion on Investigational Drugs. 12 (3): 491–499. doi:10.1517/13543784.12.3.491. ISSN 1354-3784.
  3. ↑ Ramesh N. Patel (3 January 2000). Stereoselective Biocatalysis. CRC Press. pp. 48–. ISBN 978-0-8247-8282-5.
  4. ↑ Lily C. Tang; Stephen J. Tang (6 December 2012). Neurochemistry in Clinical Application. Springer Science & Business Media. pp. 81–. ISBN 978-1-4615-1857-0.
  5. ↑ AdisInsight. "Cericlamine". Retrieved 13 January 2016.
  6. ↑ U.S. Patent 6,121,491
This article is issued from Wikipedia - version of the 10/24/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.